Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C178056> ?p ?o ?g. }
Showing items 1 to 21 of
21
with 100 items per page.
- NCIT_C178056 IAO_0000115 "Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia. (Dimopoulos MA, Tedeschi A, Trotman J, Garcia Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C. Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia for the iNNOVATE Study Group and the European Consortium for Waldenstrom's Macroglobulinemia. N Engl J Med 2018;378:2399-410.)" @default.
- NCIT_C178056 NCIT_NHC0 "C178056" @default.
- NCIT_C178056 NCIT_P106 "Intellectual Product" @default.
- NCIT_C178056 NCIT_P108 "Dimopoulos Waldenstroms Macroglobulinemia 2018 Oncology Response Criteria" @default.
- NCIT_C178056 NCIT_P208 "CL1647627" @default.
- NCIT_C178056 NCIT_P322 "CDISC" @default.
- NCIT_C178056 NCIT_P325 "Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia. (Dimopoulos MA, Tedeschi A, Trotman J, Garcia Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C. Phase 3 Trial of Ibrutinib plus Rituximab in Waldenstrom's Macroglobulinemia for the iNNOVATE Study Group and the European Consortium for Waldenstrom's Macroglobulinemia. N Engl J Med 2018;378:2399-410.)" @default.
- NCIT_C178056 normalizedInformationContent "100" @default.
- NCIT_C178056 referenceCount "1" @default.
- NCIT_C178056 hasExactSynonym "DIMOPOULOS WALDENSTROMS MACROGLOBULINEMIA 2018" @default.
- NCIT_C178056 hasExactSynonym "Dimopoulos Waldenstroms Macroglobulinemia 2018 Oncology Response Criteria" @default.
- NCIT_C178056 inSubset NCIT_C124298 @default.
- NCIT_C178056 inSubset NCIT_C61410 @default.
- NCIT_C178056 inSubset NCIT_C66830 @default.
- NCIT_C178056 type Class @default.
- NCIT_C178056 isDefinedBy ncit.owl @default.
- NCIT_C178056 label "Dimopoulos Waldenstroms Macroglobulinemia 2018 Oncology Response Criteria" @default.
- NCIT_C178056 subClassOf NCIT_C125932 @default.
- NCIT_C178056 subClassOf NCIT_C178056 @default.
- NCIT_C178056 subClassOf NCIT_C20181 @default.
- NCIT_C178056 subClassOf NCIT_C25466 @default.